Jazz Pharmaceuticals to Participate in the 2025 Wells Fargo Healthcare Conference

Rhea-AI Summary

Jazz Pharmaceuticals (NASDAQ:JAZZ) announced its participation in the upcoming 2025 Wells Fargo Healthcare Conference. Company management will conduct a fireside chat on September 3, 2025, at 6:30 a.m. PDT.

The presentation will be accessible through a live audio webcast on the company's investor relations website, with replays available for 30 days. Jazz Pharmaceuticals is a global biopharma company focused on developing life-changing medicines for sleep disorders, epilepsy, and cancer treatments.

News Market Reaction – JAZZ

+2.14%

+2.14% Session close to close

In the Aug 22 session, JAZZ gained 2.14%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DUBLIN, Aug. 21, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 2025 Wells Fargo Healthcare Conference. Company management will participate in a fireside chat on Wednesday, September 3, 2025, at 6:30 a.m. PDT / 9:30 p.m. EDT / 2:30 p.m. IST.

An audio webcast of the fireside chat will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.

Audio webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.

Contacts:
Investors:
Jack Spinks
Executive Director, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717

Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948

View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-the-2025-wells-fargo-healthcare-conference-302533954.html

SOURCE Jazz Pharmaceuticals plc

FAQ

When is Jazz Pharmaceuticals (JAZZ) presenting at the Wells Fargo Healthcare Conference 2025?

Jazz Pharmaceuticals will present on Wednesday, September 3, 2025, at 6:30 a.m. PDT / 9:30 p.m. EDT / 2:30 p.m. IST.

How can investors access Jazz Pharmaceuticals' Wells Fargo conference presentation?

Investors can access the audio webcast through the Investors section of Jazz Pharmaceuticals' website at investor.jazzpharma.com. A replay will be available for 30 days after the presentation.

What are Jazz Pharmaceuticals' main therapeutic areas?

Jazz Pharmaceuticals focuses on developing medicines for sleep disorders, epilepsy, and cancer treatments, with ongoing research and development in oncology and neuroscience.

Where is Jazz Pharmaceuticals headquartered?

Jazz Pharmaceuticals is headquartered in Dublin, Ireland, with research and development laboratories and manufacturing facilities across multiple countries.